English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Dec 1, 2025

Six companies continue work on cell therapy despite recent industry exits
+ Pharmaceuticals
Patient Daily | Dec 1, 2025

New hereditary angioedema treatments expand options but patient switching remains limited

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation